PLx Pharma Inc reports results for the quarter ended in June - Earnings Summary

PLx Pharma Winddown

06/08/2021 14:12

* PLx Pharma Inc  PLXP.OQ  reported a quarterly adjusted loss
of 79 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 22 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* PLx Pharma Inc's reported EPS for the quarter was a loss of 79
cents​.
* The mean earnings estimate of analysts had fallen by
about 6.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* PLx Pharma Inc shares had risen by 33.6% this quarter and
gained 234.1% so far this year.
* The company reported a quarterly loss of $18.71 million.
* Wall Street's median 12-month price target for PLx Pharma Inc
is $21.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 6 at 01:12 p.m.  ​All
figures in US dollars unless otherwise stated